Acil-500mg Inj.
MRP: ₹0.00
Packaging
1 x 1 INJECTION
Composition
Aciclovir 500mg
Company
D.R. John Lab
MRP: ₹0.00
Packaging
1 x 1 INJECTION
Composition
Aciclovir 500mg
Company
D.R. John Lab
| Medicine | Company | Price | You Save |
|---|---|---|---|
| Axovir 500mg Injection | Samarth Pharma | ₹466.28 | — |
| Acivir 500 Infusion | Cipla | ₹502.58 | — |
Aciclor is used as Antivirals / Topical Antivirals / Eye Anti-Infectives & Antiseptics.
Nausea, vomiting, headache, diarrhoea, rash, haematological changes (occasional), increase in liver enzymes, burning, itching or erythema (topical use). Eye application may produce stinging, superficial punctate keratopathy, blepharitis or conjunctivitis. IV administration: Local reaction, pain, inflammation, phlebitis, extravasation leads to ulceration. Increase in BUN and/or creatinine. Rarely, renal failure. Potentially Fatal: Occasionally neurotoxicity after IV use: Lethargy, confusion, agitation, tremors, seizures, coma.
Probenecid decreases urinary excretion and increases half-life. Risk of renal impairment increased by other nephrotoxic drugs.
Hypersensitivity
Activity against HSV types I and II and varicella-zoster virus is due to intracellular conversion of aciclovir to the monophosphate by viral thymidine kinase with subsequent conversion to the diphosphate and active triphosphate by cellular enzymes. This active form inhibits viral DNA synthesis and replication by interfering with viral DNA polymerase enzyme and being incorporated into viral DNA. Absorption: 15-30% is absorbed from the GI tract (oral), slightly absorbed from the skin (topical), absorbed from the eye (ophthalmic). Distribution: CSF (50% of conc is similar to those in plasma); crosses the placenta and enters breast milk (concentrations 3 times higher than in maternal serum). Protein-binding: 9-33%. Excretion: Via kidney by glomerular filtration and tubular secretion (14% as unchanged), via faeces (2%); elimination half-life: 2-3 hr (normal renal function), 19.5% (anuric patients), 5-7% (haemodialysis patients).
Renal impairment. Pregnancy, lactation. Neurological abnormalities with significant hypoxia, serious hepatic or electrolyte abnormalities. Maintain adequate hydration.
Take orally with food and water, as directed by your physician.
Keep in a cool, dry place away from sunlight and moisture.
This content is for educational purposes only. Please consult your doctor before use.
| Brand Name | Form | Price |
|---|---|---|
| Acil-250mg Inj. | INJECTION | ₹0.00 |
| Acil-500mg Inj. | INJECTION | ₹0.00 |
| Carvic Cap | CAP | ₹0.00 |
| Jidox-100mg DT | TAB | ₹0.00 |
| Jidox-200mg DT | TAB | ₹0.00 |
| Jocal Tab | TAB | ₹0.00 |
| Jocal-C Cap | CAP | ₹89.50 |
| Jox Suspension | SYRUP | ₹0.00 |
| Jox-200 Tab | TAB | ₹0.00 |
| Jox-400 Tab | TAB | ₹0.00 |
| Joxcy-250 Tab | TAB | ₹0.00 |
| Joxcy-500 Tab | TAB | ₹0.00 |
| Jublin-150mg Cap | CAP | ₹0.00 |
| Jublin-75mg Cap | CAP | ₹0.00 |
| Jublin-M Cap | CAP | ₹0.00 |
Written by: SastiMedic Medical Team
Reviewed by: Registered Pharmacist